Pacira Biosciences, Inc.
PCRX
Revenue
178.02M
▲10.91M▲6.53%
3 Months ChangeAssets
1.65B
▲63.50M▲4.01%
3 Months ChangeLiabilities
767.54M
▲76.38M▲11.05%
3 Months ChangeFree Cash Flow
46.27M
▲33.70M▲268.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-21
Form 8-K
ID: 0001396814-24-000129
2024-09-27
Form 8-K
ID: 0001396814-24-000124
2024-09-09
Form 8-K
ID: 0001396814-24-000120
2024-08-09
Form 8-K
ID: 0001396814-24-000103
2024-07-30
Form 10-Q
ID: 0001396814-24-000098
2024-07-30
Form 8-K
ID: 0001396814-24-000097
2024-06-13
Form 8-K
ID: 0001396814-24-000057
2024-05-14
Form 8-K
ID: 0001104659-24-061135
2024-05-08
Form 8-K
ID: 0001104659-24-058675
2024-05-07
Form 10-Q
ID: 0001396814-24-000045